A randomized, multicenter, phase III study of gemcitabine combined with capecitabine versus gemcitabine alone as first-line chemotherapy for advanced pancreatic cancer in South Korea-Reference-Cited by-同舟云学术

A randomized, multicenter, phase III study of gemcitabine combined with capecitabine versus gemcitabine alone as first-line chemotherapy for advanced pancreatic cancer in South Korea

Published:2017-01 Issue:1 Volume:96 Page:e5702
ISSN:0025-7974
Container-title:Medicine
language:en
Short-container-title:

Author:

Lee Hee Seung,Chung Moon Jae,Park Jeong Youp,Bang Seungmin,Park Seung Woo,Kim Ho Gak,Noh Myung Hwan,Lee Sang Hyub,Kim Yong-Tae,Kim Hyo Jung,Kim Chang Duck,Lee Dong Ki,Cho Kwang Bum,Cho Chang Min,Moon Jong Ho,Kim Dong Uk,Kang Dae Hwan,Cheon Young Koog,Choi Ho Soon,Kim Tae Hyeon,Kim Jae Kwang,Moon Jieun,Shin Hye Jung,Song Si Young

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

General Medicine

Reference23 articles.

1. Cancer statistics, 2015;Siegel;CA Cancer J Clin,2015

2. Clinical cancer advances 2010: annual report on progress against cancer from the American Society of Clinical Oncology;Kris;J Clin Oncol,2010

3. Cancer statistics in Korea: incidence, mortality, survival, and prevalence in 2012;Jung;Cancer Res Treat,2015

4. Pancreatic cancer;Kleeff;Nat Rev Dis Primers,2016

5. Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial;Burris;J Clin Oncol,1997

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A systematic analysis with the hierarchical cluster analysis strategy on the complex interaction of TERT and CTNNB1 somatic mutations in Vietnamese hepatocellular carcinoma patients;Gene;2024-11

2. Reply to C. Springfeld et al;Journal of Clinical Oncology;2023-09-01

3. The efficacy and safety of gemcitabine-based combination therapy vs. gemcitabine alone for the treatment of advanced pancreatic cancer: a systematic review and meta-analysis;Journal of Gastrointestinal Oncology;2022-08

4. Comparative Outcomes of First-Line Chemotherapy for Metastatic Pancreatic Cancer Among the Regimens Used in Japan;JAMA Network Open;2022-01-31

5. Safety and efficiency of combination treatment including high-intensity focused ultrasound therapy in patients with pancreatic cancer;Onkologiya. Zhurnal imeni P.A.Gertsena;2022